樂心醫療(300562.SZ):完成生產許可證變更
格隆匯4月5日丨樂心醫療(300562.SZ)公佈,公司於近日收到廣東省藥品監督管理局(“廣東藥監局”)下發的《醫療器械生產許可證》(許可證編號:粵食藥監械生產許20071486號),生產範圍:II類07醫用診察和監護器械-03生理參數分析測量設備,II類18婦產科、輔助生殖和避孕器械-02婦產科測量、監護設備。
公司此次變更《醫療器械生產許可證》主要系新增生產產品列表:醫用電子血壓計,型號:2000-C,註冊證編號:粵械注準 20222070047。目前,公司已完成上述變更。
公司致力於成為世界級的健康IoT及數字健康服務提供商,始終高度重視醫療器械標準符合性,推動全系列產品向醫療級方向發展。此次生產許可證的變更有利於增強公司的綜合競爭力和市場拓展能力,完善公司醫療器械資質體系,對公司未來的經營將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.